Early elevation in circulating levels of C-telopeptides of type II collagen predicts structural damage in articular cartilage in the rodent model of collagen-induced arthritis

Arthritis and Rheumatism

Volumn 54, Issue 9, 2006, Pages 2886-2890

  Oestergaard, Svetlana ^a   Chouinard, Luc ^b   Doyle, Nancy ^b   Smith, Susan Y ^b   Tankó, László B ^c   Qvist, Per ^a  

^a NORDIC BIOSCIENCE A S   (Denmark)

^b CHARLES RIVER LABORATORIES   (United States)

^c CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN; COLLAGEN TYPE 2; EPITOPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE SEVERITY; EVALUATION; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; MONITORING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SYNOVIAL FLUID;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CARTILAGE, ARTICULAR; COLLAGEN; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; FEMALE; JOINTS; PEPTIDES; RATS; RATS, INBRED LEW;

EID: 33749338444     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22083     Document Type: Article

References (15)

1. Mili F, Helmick CG, Zack MM. Prevalence of arthritis: analysis of data from the US Behavioral Risk Factor Surveillance System, 1996-99. J Rheumatol 2002;29:1981-8.
2. Joe B, Griffiths MM, Remmers EF, Wilder RL. Animal models of rheumatoid arthritis and related inflammation [review]. Curr Rheumatol Rep 1999;1:139-48.
3. Vierboom MP, Jonker M, Bontrop RE, 't Hart B. Modeling human arthritic diseases in nonhuman primates [review]. Arthritis Res Ther 2005;7:145-54.
4. Larsson E, Harris HE, Lorentzen JC, Larsson A, Mansson B, Klareskog L, et al. Serum concentration of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats. Rheumatology (Oxford) 2002;41:996-1000.
5. Elsaid KA, Chichester CO. Review: collagen markers in early arthritic diseases. Clin Chim Acta 2006;365:68-77.
6. Oestergaard S, Chouinard L, Doyle N, Karsdal, MA, Smith, SY, Qvist P, et al. The utility of measuring C-terminal telopeptides of collagen type II (CTX-II) in serum and synovial fluid samples for estimation of articular cartilage status in experimental models of destructive joint diseases. Osteoarthritis Cartilage 2006;14:670-9.
7. Pagani F, Francucci CM, Moro L. Markers of bone turnover: biochemical and clinical perspectives [review]. J Endocrinol Invest 2005;28(10 Suppl):8-13.
8. Bendele A. Animal models of rheumatoid arthritis. J Musculoskelet Neuronal Interact 2001;1:377-85.
9. Oestergaard S, Sondergaard BC, Hoegh-Andersen P, Henriksen K, Qvist P, Christiansen C, et al. Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiation. Arthritis Rheum 2006;54:2441-51.
10. Hoegh-Andersen P, Tanko LB, Andersen TL, Lundberg CV, Mo JA, Heegaard AM. Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application. Arthritis Res Ther 2004;6:R169-80.
11. Ishikawa T, Nishigaki F, Christgau S, Noto T, Mo J, From N, et al. Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type II C-telopeptide fragments. J Rheumatol 2004;31:1174-9.
12. De Ceuninck F, Sabatini M, Renoux V, de Nanteuil G, Pastoureau P. Urinary collagen type II C-telopeptide fragments are sensitive markers of matrix metalloproteinase-dependent cartilage degradation in rat adjuvant-induced arthritis. J Rheumatol 2003;30:1561-4.
13. Garnero P, Landewe R, Boers M, Verhoeven A, van der Linden S, Christgau S, et al. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum 2002;46:2847-56.
14. Stoop R, van der Kraan PM, Buma P, Hollander AP, Poole R, van den Berg WB. Denaturation of type II collagen in articular cartilage in experimental murine arthritis: evidence for collagen degradation in both reversible and irreversible cartilage damage. J Pathol 1999;188:329-37.
15. Landewe R, Geusens P, Boers M, van der Heijde D, Lems W, te Koppele J, et al. Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis. Arthritis Rheum 2004;50:1390-9.